Please login to the form below

Not currently logged in

Diabetes puts economic growth at risk, says IDF

Comments come on World Diabetes Day
World Diabetes Day

The increasing prevalence of diabetes in the world's richest nations is putting economic growth at risk, according to the International Diabetes Federation (IDF).

To coincide with World Diabetes Day today the IDF published figures suggesting that diabetes healthcare costs will reach $566bn by the end of 2014 across the G20 countries - accounting for 15% of the total healthcare budget of these high-income nations.

The cost will be exacerbated by late diagnosis and the development of complications, such as eye conditions and limb amputation, said the IDF, which issued a call for G20 governments to implement national plans to prevent diabetes.

The focus is on type 2 diabetes, the form of the condition that tends to develop later in adulthood due to lifestyle and diet, rather than type 1 diabetes, a lifelong condition where the body can't produce enough insulin.

According to the IDF, around 70% of type 2 diabetes cases can be prevented or delayed by adopting healthier lifestyles. This equates to about 150 million new cases of type 2 diabetes by 2035.

“It is vital that governments realise that the rising number of diabetes cases negatively impacts on development and has the potential to bankrupt healthcare systems,” said Dr Petra Wilson, CEO of the IDF. “Making small and effective investments around healthy eating and living makes economic and social sense.”

Several organisations are taking part in activities to market World Diabetes Day and raise awareness of the condition and how to live a healthy lifestyle.

The charity Diabetes UK launched its Enjoy Food campaign in partnership with supermarket chain Tesco to promote the message that healthy eating should be an enjoyable part of life for families with diabetes.

The campaign, which includes recipes and expert diabetes nutritional information, comes after a survey found that just 40% of people in the UK would find it easy to tailor a meal for someone with diabetes.

Pharma companies have also been involved in World Diabetes Day, including Novo Nordisk, which announced that the Chinese cities of Tianjin and Shanghai are to join its Cities Changing Diabetes campaign to tackle diabetes in major cities. This follows similar campaigns in from the Danish pharma company in Mexico City, Copenhagen and Houston.

14th November 2014

From: Sales, Healthcare



COVID-19 Updates and Daily News

Featured jobs


Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....